Latest filing published 11 Dec 2020 for Adaptive Biotechnologies Corp, €270k.
Filing timeline
BuySaleInsider track record
Charles Sang: trading record in brief
All filings by Charles Sang on record concern Adaptive Biotechnologies Corp. Between 15 May 2020 and 11 December 2020, the trades on record add up to 9 filings.
On the market, this insider has only sold: 4 sales, €5.5M in total. Outside the open market, there are 5 option exercises.
On 11 December 2020 came the latest disclosure, an option exercise for €270k in Adaptive Biotechnologies Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Charles Sang
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ US$6.554.3% of flowCommon StockSEC:0001209191-20-063102:0
- 50,000 shares@ US$56.1336.6% of flowCommon StockSEC:0001209191-20-063102:1
- 25,000 shares@ US$6.552.2% of flowCommon StockSEC:0001209191-20-050780:0
- 25,000 shares@ US$42.5014.2% of flowCommon StockSEC:0001209191-20-050780:1
- 25,000 shares@ US$6.322.1% of flowCommon StockSEC:0001209191-20-050780:2
- 25,000 shares@ US$44.0014.7% of flowCommon StockSEC:0001209191-20-050780:3
- 20,000 shares@ US$6.321.9% of flowCommon StockSEC:0001209191-20-030299:0
- 20,000 shares@ US$6.551.9% of flowCommon StockSEC:0001209191-20-030299:1
- 40,000 shares@ US$38.0122.3% of flowCommon StockSEC:0001209191-20-030299:2
9 of 9 declarations
